GSA Capital Partners »

Eagle Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $435k 83k 5.23
2023-09-30 $401k 25k 15.76
2023-06-30 $711k 37k 19.44
2023-03-31 $404k 14k 28.40
2022-09-30 $611k 23k 26.41
2022-06-30 $758k 17k 44.44
2022-03-31 $813k 16k 49.51
2021-12-31 $243k 4.8k 51.02
2020-03-31 $283k 6.1k 46.08
2019-12-31 $623k 10k 60.09
2019-09-30 $670k 12k 56.58
2019-06-30 $1.1M 19k 55.67
2019-03-31 $1.2M 23k 50.49
2018-12-31 $1.3M 32k 40.28
2018-09-30 $1.7M 24k 69.33
2018-06-30 $401k 5.3k 75.66
2018-03-31 $411k 7.8k 52.69
2017-12-31 $2.1M 40k 53.42
2017-09-30 $948k 16k 59.62
2017-06-30 $2.2M 29k 78.88
2017-03-31 $2.7M 32k 82.94
2016-03-31 $1.3M 32k 40.50
2015-12-31 $688k 7.8k 88.69
2015-09-30 $751k 10k 74.03
2015-03-31 $901k 22k 41.91